European health systems are under pressure because of the aging population, the increasing amount of chronic diseases and a rise of healthcare costs caused by…
Polyneuron Pharmaceuticals, a BaseLaunch portfolio company, has concluded the extension of its Series A financing round. With further investment of 14 million francs, the startup has…
Special Report: The latest addition to the partner portfolio all the way from Asia Pacific. A warm welcome to Bridge Biotherapeutics, for which CEO, James Lee,…
We welcome back Roivant Sciences with open arms for the continuation of their partnership with BaseLaunch Phase II. Sascha Bucher, Head of Global Transactions at…
“Go start a biotech company in a strong biotech ecosystem” is our conclusion from this Nature paper, which tracks down every biotech start-up emerging (between…
Leading venture capital firm Sofinnova Partners led the Series A financing, together with New Enterprise Associates, which co-led the round Basel, Switzerland, 28 March 2019–Polyneuron…